Compare Cronos Group Inc (CRON) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs First Citizens BancShares Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while First Citizens BancShares Inc trades at $2,068.39 (market cap $22.94B). The key difference: First Citizens BancShares Inc is far larger — about 19.4× Cronos Group Inc's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and First Citizens BancShares Inc for 29 Days on average.
| CRON | FCNCA | |
|---|---|---|
Market Cap | $1.18B | $22.94B |
Volume | 968,037 | 91,668 |
Sector | Health | Sector/Thematic |
52-Week High | $3.55 | $2.29K |
52-Week Low | $2.30 | $1.64K |
Typical Hold Time | 22 Days | 29 Days |
Enterprise Value | $387.62M | — |
Dividend Yield | — | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.23, down 0.31% with a bearish technical signal. Recent earnings show volatility with Q2 2026 beating expectations ($0.09 vs $0.01) but Q4 2025 missing. Revenue grew from $118M (2024) to $147M (2025), though net income turned negative at -$9M. The company maintains strong liquidity with $827M cash and no debt, highlighted in recent investor day presentations.
Outlook is mixed: analyst consensus leans Hold (60%) with cautious optimism on international expansion and margin improvements. Key risks include sustained negative cash flow (-$67M in 2025) and competitive pressures. Upside hinges on execution of growth initiatives in Canada and Europe, with profitability projections for 2026.
First Citizens BancShares (FCNCA) trades at $2,068.39, down slightly by 0.15% with a bearish technical signal. The company demonstrates strong fundamentals with a P/E of 11.08 and net income margin of 25.23%, having beaten earnings estimates for three consecutive quarters. Recent business developments include branch acquisitions and new financing initiatives, while analyst consensus shows 82% hold ratings with a $2,290 price target.
FCNCA presents a mixed outlook with strong profitability metrics offset by bearish technical indicators. Investment opportunity lies in continued earnings outperformance and strategic expansion, while risks include negative cash flow trends and institutional selling pressure. The stock offers value characteristics but requires monitoring of technical support levels near $2,028.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
